| 1 |
34824002 | A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC). | 2022 Apr |
2 |
| 2 |
31017696 | A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling. | 2019 Jun |
1 |
| 3 |
28463227 | Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer. | 2017 Jun 1 |
1 |
| 4 |
24844235 | Targeting hormonal signaling pathways in castration resistant prostate cancer. | 2014 |
1 |